OWL
Desconocido
REDDSTAR: Repair of Diabetic Damage by Stromal Cell Administration
OWL BIOMEDICAL INC
participó en un
FP7:
50 million diabetic EU citizens are using approved anti-diabetic agents to control their glycaemia. However, suboptimal glycemic control lea...
Financiado
Financiado
* No se disponen de datos de la empresa actual.